NCT05879367 2025-06-25
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Orbus Therapeutics, Inc.
Phase 1 Recruiting
Orbus Therapeutics, Inc.
New Approaches to Neuroblastoma Therapy Consortium
Milton S. Hershey Medical Center